颅内动脉粥样硬化性大血管闭塞血管内治疗结局:11,326例系统综述与荟萃分析
汇总未调整比较显示,ICAD与较低的成功再灌注 odds 相关,症状性颅内出血风险较低,但功能独立和死亡率无显著差异;证据确定性低至极低,需随机试验验证。
要点
- ICAD相关LVO血管内治疗后成功再灌注 odds 较低(OR 0.46),报告时应提示再通难度可能增加。
- ICAD相关LVO症状性颅内出血风险较低(OR 0.72),但功能结局和死亡率与非ICAD无显著差异。
- 证据确定性低至极低,解读ICAD病因对预后的影响需谨慎,不能据此改变临床决策。
英文原文(摘要)· 点击展开
BACKGROUND: Intracranial atherosclerotic disease (ICAD) is a major cause of large vessel occlusion (LVO) stroke and presents unique challenges for endovascular treatment (EVT).
PURPOSE: To compare angiographic and clinical outcomes after EVT in patients with ICAD-related versus non-ICAD LVO.
DATA SOURCES: PubMed, Embase, Web of Science, and Cochrane Central Register of Controlled Trials were searched from inception through July 2025.
STUDY SELECTION: Studies enrolling adults with LVO undergoing EVT that directly compared ICAD and non-ICAD etiologies were included.
DATA ANALYSIS: Random-effects models were used to pool odds ratios (OR). Risk of bias was assessed with ROBINS-I, and certainty of evidence (CoE) was evaluated using GRADE.
DATA SYNTHESIS: Eighteen studies (3 prospective and 15 retrospective) comprising 11,326 patients (1,571 ICAD; 9,755 non-ICAD) were included. Mean age across cohorts was 72.8 years, and hypertension was the most common comorbidity. ICAD was associated with lower odds of successful reperfusion (OR, 0.46; 95%CI, 0.31-0.70; p<0.001; very-low CoE) and lower risk of sICH (OR, 0.72; 95%CI, 0.54-0.96; p=0.025; low CoE). No significant differences were observed for functional independence (OR, 0.90; 95%CI, 0.67-1.22; p=0.51; very-low CoE), favorable functional outcome (OR, 0.80; 95%CI, 0.43-1.51; p=0.45; very-low CoE), or mortality (OR, 1.16; 95%CI, 0.77-1.75; p=0.48; very-low CoE).
LIMITATIONS: Included studies were observational, most were retrospective, and pooled estimates were derived from unadjusted comparisons.
CONCLUSIONS: In pooled unadjusted comparisons, ICAD was associated with lower reperfusion success but similar functional and mortality outcomes compared to non-ICAD LVO, alongside a lower risk of symptomatic hemorrhage. These findings highlight the distinct pathophysiology of ICAD-LVO and the need for tailored EVT strategies and randomized trials for this population.
引用
- Woehl LO, Foletto PC, Peruzzo JG, et al. Outcomes of Endovascular Treatment in Large Vessel Occlusions Due to Intracranial Atherosclerotic Disease: A Systematic Review and Updated Meta-Analysis of 11,326 Patients. AJNR Am J Neuroradiol. 2026. PMID: 42362351. doi:10.3174/ajnr.A9499
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。